Why rebrands fail in biotech and life sciences

You've watched companies in biotech and life sciences spend months on a rebrand and end up with a new logo and the same confusion. The team doesn't know what to say. The sales deck still sounds like everyone else. You don't want that to be your story.

Rebrands fail when the first conversation is about colors and fonts. In biotech and life sciences, the science is complex and the audiences are specific. If you don't decide what the company stands for first, the new identity has nothing to express. You end up with a prettier version of the same unclear message.

The scope depends on how much positioning work you've already done. If your leadership team is aligned on who you are and who you're for, the visual identity moves faster. If not, that's where we start. A biotech rebrand can mean refreshing a mark or rebuilding the entire system across every touchpoint. The bigger the gap between your current story and the one you need to tell, the more work it takes.

Start with a positioning session. Before any design work, get clear on your difference and your audience. I work directly with CEOs and leadership teams to sharpen that position. Then SliiceXR handles the brand identity execution. Call me. Let's define what your company stands for before you invest in a new look.

You'll have a brand identity your sales team can explain in one sentence. Your website and your pitch deck will tell the same story. You won't worry about becoming a cautionary tale because your rebrand will actually mean something.

Other questions about brand identity for Biotech and Life Sciences